MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

被引：0
|
作者：
Rubin, David
Pollack, Paul
Hunter, Theresa
Shan, Mingyang
Chan, Lai-Shan
Deckard, Deanilee
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：S14 / S15
页数：2
相关论文
共 50 条
  • [31] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Dubinsky, M. C.
    D'Haens, G.
    Dewit, O.
    Juillerat, P.
    Panaccione, R.
    Fujii, T.
    Lacerda, A. P.
    Dubcenco, E.
    Anyanwu, S.
    Doshi, C.
    Mallick, M.
    Garrison, A.
    Liu, J.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I104 - I106
  • [32] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel
    Doshi, Chirag
    Mallick, Madhuja
    Garrison, Andrew
    Liu, John
    Loftus, Edward V., Jr.
    SWISS MEDICAL WEEKLY, 2023, 153 : 9S - 10S
  • [33] Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately to Severely Active Crohn's Disease
    Sands, Bruce E.
    Gasink, Christopher
    Jacobstein, Douglas
    Ott, Elyssa
    Lang, Yinghua
    Ramachandran, Paraneedharan
    Ghosh, Subrata
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S329 - S330
  • [34] CORTICOSTEROID DISCONTINUATION AND CLINICAL OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE TREATED WITH UPADACITINIB
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel
    Doshi, Chirag
    Mallick, Madhuja
    Garrison, Andrew
    Liu, Jianzhong
    Loftus, Edward V.
    GASTROENTEROLOGY, 2023, 164 (06) : S1087 - S1088
  • [35] Meta-analysis of placebo remission rate for patients with moderately to severely active Crohn's disease
    Loftus, Edward, Jr.
    Wu, Eric
    Johnson, Scott
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S380 - S381
  • [36] Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease
    Harris, Sarah
    Feagan, Brian G.
    Hanauer, Stephen
    Vermeire, Severine
    Ghosh, Subrata
    Yan, Jim
    Wu, Chun
    Hu, Yanhua
    Maddux, Rachel
    Wolf, Douglas C.
    D'Haens, Geert
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (06) : 2044 - 2054
  • [37] Dual Advanced Therapies and Novel Pharmacotherapies for Moderately to Severely Active Crohn's Disease
    Tse, Chung Sang
    Dulai, Parambir S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) : 283 - 298
  • [38] Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease
    Walters, Thomas D.
    Faubion, William A.
    Griffiths, Anne M.
    Baldassano, Robert N.
    Escher, Johanna
    Ruemmele, Frank M.
    Hyams, Jeffrey S.
    Lazar, Andreas
    Eichner, Samantha
    Huang, Bidan
    Li, Yao
    Thakkar, Roopal B.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (06) : 967 - 975
  • [39] Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
    Rimola, J.
    Rodriguez, S.
    Garcia-Bosch, O.
    Ordas, I.
    Ayala, E.
    Aceituno, M.
    Pellise, M.
    Ayuso, C.
    Ricart, E.
    Donoso, L.
    Panes, J.
    GUT, 2009, 58 (08) : 1113 - 1120
  • [40] Assessment of perianal disease activity in patients with Crohn's disease
    Losco, Alessandra
    Vigano, Chiara
    Conte, Dario
    Cesana, Bruno M.
    Basilisco, Guido
    GASTROENTEROLOGY, 2007, 132 (04) : A360 - A360
12345